Comparing adults with severe SARS-CoV-2 or influenza infection: South Africa, 2016–2021

Southern African Journal of Infectious Diseases

 
 
Field Value
 
Title Comparing adults with severe SARS-CoV-2 or influenza infection: South Africa, 2016–2021
 
Creator Els, Fiona Kleynhans, Jackie Wolter, Nicole du Plessis, Mignon Moosa, Fahima Tempia, Stefano Makhasi, Mvuyo Nel, Jeremy Dawood, Halima Meiring, Susan von Gottberg, Anne Cohen, Cheryl Walaza, Sibongile
 
Subject Epidemiology; infectious disease; respiratory disease; influenza; SARS-CoV-2 COVID-19; pneumonia surveillance; risk factors; severe respiratory illness; HIV; pre-pandemic.
Description Background: Comparisons of the characteristics of individuals hospitalised with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or seasonal influenza in low-to middle-income countries with high human immunodeficiency virus (HIV) prevalence are limited.Objectives: Determine the epidemiological differences with those hospitalised with influenza or SARS-CoV-2 infection.Method: We investigated hospitalised individuals ≥18 years of age testing positive for seasonal influenza (2016–2019) or SARS-CoV-2 (2020–2021). We used random effects multivariable logistic regression, controlling for clustering by site, to evaluate differences among adults hospitalised with influenza or SARS-CoV-2 infection.Results: Compared to individuals with influenza, individuals with SARS-CoV-2 infection were more likely to be diabetic (adjusted odds ratio [aOR]: 1.70, 95% confidence interval [CI]: 1.11–2.61) or die in hospital (aOR: 2.57, 95% CI: 1.61–4.12). Additionally, those with SARS-CoV-2 infection were less likely to be living with HIV (not immunosuppressed) (aOR: 0.50, 95% CI: 0.34–0.73) or living with HIV (immunosuppressed) (aOR: 0.27, 95% CI: 0.18–0.39) compared to not living with HIV and less likely to be asthmatic (aOR: 0.21, 95% CI: 0.13–0.33) rather than those living with influenza.Conclusion: Individuals hospitalised with SARS-CoV-2 had different characteristics to individuals hospitalised with influenza before the coronavirus disease 2019 (COVID-19) pandemic. Risk factors should be considered in health management especially as we move into an era of co-circulation of SARS-CoV-2 and influenza pathogens.Contribution: Identifying groups at high risk of severe disease could help to better monitor, prevent and control SARS-CoV-2 or influenza severe disease.
 
Publisher AOSIS Publishing
 
Contributor
Date 2024-07-26
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — Surveillance data analysis
Format text/html application/epub+zip text/xml application/pdf
Identifier 10.4102/sajid.v39i1.574
 
Source Southern African Journal of Infectious Diseases; Vol 39, No 1 (2024); 10 pages 2313-1810 2312-0053
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://sajid.co.za/index.php/sajid/article/view/574/1548 https://sajid.co.za/index.php/sajid/article/view/574/1549 https://sajid.co.za/index.php/sajid/article/view/574/1550 https://sajid.co.za/index.php/sajid/article/view/574/1551
 
Coverage South Africa 2016-2021 Age; Sex; Race; HIV infection; Underlying conditions; BMI; Astham; Diabetes; Ocygen therapy; mechanical ventilation; hospitalisation; ICU admission; Outcome
Rights Copyright (c) 2024 Fiona Els, Jackie Kleynhans, Nicole Wolter, Mignon du Plessis, Fahima Moosa, Stefano Tempia, Mvuyo Makhasi, Jeremy Nel, Halima Dawood, Susan Meiring, Anne von Gottberg, Cheryl Cohen, Sibongile Walaza https://creativecommons.org/licenses/by/4.0
ADVERTISEMENT